Full-Time
Confirmed live in the last 24 hours
Non-invasive cardiac testing for heart disease
$84.5k - $110kAnnually
Senior
Remote in USA
Candidates must be located in one of the specified states or be able to relocate.
You match the following HeartFlow's candidate preferences
Employers are more likely to interview you if you match these preferences:
HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.
Company Size
501-1,000
Company Stage
Series F
Total Funding
$858.5M
Headquarters
Redwood City, California
Founded
2010
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Stock Options
401(k) Company Match
HeartFlow and Boone Heart Institute Launch GAMEFILM Registry to Study Heart Health in Retired NFL Players. by Fred Pennic 01/22/2025 Leave a Comment. What You Should Know: – HeartFlow, a global leader in AI-driven heart care solutions, and Boone Heart Institute, a renowned cardiovascular care provider in Denver, today announced the launch of the GAMEFILM Registry. – GAMEFILM Registry will utilize advanced imaging and AI technology to assess and better understand coronary artery disease (CAD) risk in retired National Football League (NFL) players.Understanding the Unique Cardiovascular Risks of Retired NFL PlayersCardiovascular disease remains the leading cause of death globally. Despite advancements in diagnostics, many heart attacks and strokes occur in individuals without prior symptoms. Early identification of high-risk individuals is critical for effective prevention and treatment. Retired NFL players often face unique cardiovascular health challenges due to the intense physical demands of their careers
HeartFlow announces new Category I CPT code from the American Medical Association for ai-enabled Plaque Analysis to assess risk for coronary artery disease.
HeartFlow launches plaque analysis platform for coronary artery disease.
Corcept appoints Monica Tellado as President, Emerging Markets.
Cardiovascular artificial intelligence (AI) software developer HeartFlow has released its RoadMap software for identifying stenoses in the coronary arteries on CT exams.